1. Igarashi Y, Akiyama Y, Shimada S, Watanabe S, Hatano M, Kodera K, Okazaki K, Tanji Y, Tsukihara S, Taniai T, Nara A, Yamane M, Kamachi A, Umemura K, Yasukawa K, Ono H, Akahoshi K, Tanabe M, Haruki K, Furukawa K, Ikegami T, Tanaka S. Identification and clinical implications of endogenous retrovirus elements suppressed by SETDB1 in hepatocellular carcinoma. JHEP Reports, 2024;7(3):101307. doi: 10.1016/j.jhepr.2024.101307.
2. Tsukihara S, Akiyama Y, Shimada S, Hatano M, Igarashi Y, Taniai T, Tanji Y, Kodera K, Yasukawa K, Umeura K, Kamachi A, Nara A, Okuno K, Tokunaga M, Katoh H, Ishikawa S, Ikegami T, Kinugasa Y, Eto K, Tanaka S. Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer. Oncogene, 2025;44(11):724-738. doi: 10.1038/s41388-024-03243-6.
3. Yasukawa K, Shimada S, Akiyama Y, Taniai T, Igarashi Y, Tsukihara S, Tanji Y, Umemura K, Kamachi A, Nara A, Yamane M, Akahoshi K, Shimizu A, Soejima Y, Tanabe M, Tanaka S. ACVR2A attenuation impacts lactate production and hyperglycolytic conditions attracting regulatory T cells in hepatocellular carcinoma. Cell Reports Medicine, 2025, in press. doi.org/10.1016/j.xcrm.2025.102038.
4. Taniai T, Shimada S, Akiyama Y, Hatano M, Yasukawa K, Igarashi Y, Tsukihara S, Tanji Y, Kodera K, Okazaki K, Haruki K, Nara A, Yagi K, Akahoshi K, Ban D, Asahina Y, Ikegami T, Tanabe M, Tanaka S. Integrative transcriptome profiling elucidates molecular and immunovascular characteristics of macrotrabecular hepatocellular carcinoma. Hepatology, 2025, in press. doi: 10.1097/HEP.0000000000001284.
5. Akahoshi K, Shindoh J, Tanabe M, Ariizumi S, Eguchi S, Okamura Y, Kaibori M, Kubo S, Simada M, Taketomi A, Takemura N, Nagano H, Nakamura M, Hasegawa K, Hatano E, Yoshizumi T, Endo I, Kokudo N, Oncological resectability criteria for hepatocellular carcinoma in the era of novel systemic therapies: the JLCA and JSHBPS Expert Consensus Statement 2023. Liver Cancer, 2024;13(6):0-10. doi: 10.1159/000538627.
6. Shindoh J, Kawamura Y, Akahoshi K, Matsumura M, Okubo S, Akuta N, Tanabe M, Kokudo N, Suzuki Y, Hashimoto M. Clinical Utility of the Novel Oncological Criteria of Resectability for Advanced Hepatocellular Carcinoma. Liver Cancer, 2024;13(6):601-609. doi: 10.1159/000539381.